Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
Date:9/21/2007

NEW YORK, Sept. 21 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced the appointment of Michael P. Tarnok to the Company's Board of Directors.

Mr. Tarnok, 53, a seasoned finance and operational executive, joins the Keryx Board with extensive pharmaceutical industry experience in a wide range of functional areas. Mr. Tarnok spent the majority of his career at Pfizer Inc., which he joined in 1989 as Finance Director - US Manufacturing, and from 2000-2007, served as Senior Vice President, Finance in Pfizer's US Pharmaceuticals Division. In this position, Mr. Tarnok handled all finance responsibilities for the division, including Contracting, Trade management, forecasting of significant product launches and Sarbanes Oxley compliance. Prior to joining Pfizer, Mr. Tarnok worked primarily in financial disciplines for ITT Rayonier, Inc., Celanese Corporation and Olivetti Corporation of America. Mr. Tarnok earned an M.B.A. in Marketing from New York University and B.S. in Accounting from St. John's University.

"We are pleased that Mike has agreed to join the Keryx Board of Directors," stated Michael S. Weiss, Chairman and Chief Executive Officer of Keryx. Weiss continued, "Mike has extensive financial, operational and manufacturing experience in the pharmaceutical industry, and we are excited to have his broad experience in the boardroom as we plan for the launch of Sulonex(TM) and the transition from a development stage company into a commercial organization. Mike played a significant role in the rapid growth of Pfizer's U.S. Pharmaceutical division and his perspective and sense of scale will be invaluable as we continue to build Keryx into a leading biotechnology company."'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Jan. 22. 2015  Varian Medical Systems (NYSE: VAR ... honored for its commitment to sustainability with inclusion on a ... the highest ranked healthcare equipment company among the Corporate Knights ... World Economic Forum at Davos, Switzerland . ...
(Date:12/24/2014)... SILVER SPRING, Md. , Dec. 24, 2014  United ... that Medtronic, Inc. (NYSE: MDT ) has ... and Drug Administration (FDA) for the use of Medtronic,s ... a newly developed catheter) for use with United Therapeutics, ...
(Date:12/24/2014)... 23, 2014 “Preparative & Process ... Flash), Consumables (Columns, Solvents, Buffers, Valves, Guages, Seals), ... Agriculture) - Forecasts to 2019” provides a detailed ... current market trends, and strategies impacting the preparative ...
(Date:12/24/2014)... December 23, 2014 On Friday, December ... the Omnibus and Continuing Resolution Appropriations Act of 2015, ... eligible to receive funding through the Congressionally Directed Medical ... (DoD). The Hydrocephalus Association (HA), working in conjunction with ...
Breaking Biology Technology:Varian Honored Among World's 100 Most Sustainable Corporations 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2
... to Identify Host Correlates of Protection Against Tuberculosis , ... OTTAWA, ... of products for biological sample collection, stabilization and preparation, today ... South African Tuberculosis Vaccine Initiative (SATVI), has chosen Oragene-DNA for ...
... 28 Dendreon Corporation (Nasdaq: DNDN ) announced ... IMPACT study in the New England Journal of Medicine ... in overall survival compared to control in men with asymptomatic ... manuscript is published in the July 29, 2010 ...
... 28 Burrill & Company, a San Francisco -based global ... Banking and Media, is pleased to announce that Shawn Cross ... , , , ... the Merchant Banking Group,s strategic growth plan, which includes a broad and ...
Cached Biology Technology:DNA Genotek's Oragene-DNA Achieves 95% Compliance Rate in South African Tuberculosis Vaccine Initiative (SATVI) 2DNA Genotek's Oragene-DNA Achieves 95% Compliance Rate in South African Tuberculosis Vaccine Initiative (SATVI) 3New England Journal of Medicine Publishes Data from Pivotal Phase 3 PROVENGE IMPACT Study 2New England Journal of Medicine Publishes Data from Pivotal Phase 3 PROVENGE IMPACT Study 3New England Journal of Medicine Publishes Data from Pivotal Phase 3 PROVENGE IMPACT Study 4New England Journal of Medicine Publishes Data from Pivotal Phase 3 PROVENGE IMPACT Study 5New England Journal of Medicine Publishes Data from Pivotal Phase 3 PROVENGE IMPACT Study 6Shawn Cross Appointed CEO of Burrill Merchant Banking Group 2Shawn Cross Appointed CEO of Burrill Merchant Banking Group 3
(Date:12/19/2014)... 18, 2014   LaunchKey , the first decentralized mobile ... Internet of Things era, today announced the close of ... was led by Metamorphic Ventures with participation from ENIAC ... and others.  LaunchKey has raised $4 million to date, ...
(Date:12/17/2014)... 16, 2014 Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ... Chemical Sensor Market 2015-2019" report to their offering. ... One major trend upcoming in this market is the ... sensors help in recording of patient data for quick ...
(Date:12/11/2014)... WINSTON SALEM, N.C. , Dec. 10, 2014  That blood ... for quite a while. Hypertension – the medical term for ... in the early 1800s, and the inflatable cuff that,s used ... That doesn,t, however, mean there,s nothing new about hypertension, its ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... A structural molecule and the cellular pump that regulates its ... ways of treating the lung infection, which is a leading ... University of Pittsburgh and the University of Iowa. Their findings ... Despite decades of research, there has been little new information ...
... key protein that regulates the biological clocks of mammals ... altering the levels of this protein can improve the ... this week,s advanced online publication of the journal ... for scientists to develop treatments for obesity and type ...
... Two researchers at Marshall University have been awarded ... the effects of omega-3 fatty acids on breast cancer ... Cancer Research Program has awarded Dr. Elaine Hardman, associate ... the Joan C. Edwards School of Medicine, and Dr. ...
Cached Biology News:Pitt/Iowa team finds cellular structural molecule can be toxic: Makes pneumonia worse 2Biologists discover biochemical link between biological clock and diabetes 2Biologists discover biochemical link between biological clock and diabetes 3Biologists discover biochemical link between biological clock and diabetes 4Marshall University researchers awarded more than $1 million for breast cancer studies 2Marshall University researchers awarded more than $1 million for breast cancer studies 3
With L-glutamine and potassium bicarbonate. Sterile, Insect cell culture tested...
Mol wt: average mol wt12,360.96 Da by calculation...
Originally developed for the culture of Drosophila; suitable for culture of other dipteran cell lines. Powder, Insect cell culture tested...
... Adaptor encodes a T7 promoter, lac ... translation initation codon and an N-terminal GST•Tag ... reported to enhance the production and in ... partners. The GST•Tag is a multi-purpose tag ...
Biology Products: